Site Search     
Each treatment path - chemotherapy, radiation, surgery, immunotherapy or a combination - is becoming more complicated because treatment options are growing. This growing complexity of treatment combined with the need for aggressive treatment of lung cancer has led to the development of the Baylor Sammons Lung Cancer Center. Clinical trials also offer another level of treatment options.
Thoracic Surgery
Surgical resection is the primary treatment for patients with early stage (Stage I or II) and selected patients with more advanced (Stage III) lung cancer. Surgical intervention includes wedge resection, lobectomy, pneumenectomy and sleeve resections.

Radiation Oncology
Radiation can play a major role in the treatment of lung cancer. Baylor Sammons Lung Cancer Center offers advanced radiation treatment techniques:

Three dimensional conformal radiation therapy
Intensity modulated radiation therapy
High-dose rate brachytherapy
CyberKnife® radiosurgery with Motion Synchrony

A treatment modality is chosen for an individual patient based on the tumor and clinical parameters. The goal is to deliver the highest dose of radiation to the tumor while sparing normal tissue. Most treatments are given on an outpatient basis.
Research Treatment Advances
Research continues to offer exciting new therapies for treating lung cancer. The Baylor Sammons Lung Cancer Center provides access to numerous clinical trials through Baylor Research Institute, in collaboration with the Mary Crowley Medical Research Center which is located on the campus of Baylor University Medical Center at Dallas, and Texas Oncology, P.A.

Physicians on the medical staff at the Baylor Sammons Lung Cancer Center understand the growing complexity of treatment options as well as the need for timely and aggressive treatment. These physicians are leading many advances in oncology education and research. This includes a new vaccine that has shown promise in suppressing non-small cell lung cancer in some patients in a trial being conducted by the Mary Crowley Medical Research Center and studies to be conducted by the Baylor Institute for Immunology Research utilizing dendritic cell-based vaccines for lung cancer.

Genomic and proteonomic profiling is offered to some patients by the Baylor Sammons Lung Cancer Center through work with the Baylor Institute for Immunology Research and the Mary Crowley Medical Research Center. Such profiling may help determine therapeutic decisions on an increasing number of new targeted therapies utilized for lung cancer management.


Physicians are members of the medical staff at one of Baylor Health Care System's subsidiary, community or affiliated medical centers and are neither employees nor agents of those medical centers, Baylor University Medical Center, or Baylor Health Care System. Photographs may include models or actors and may not represent actual patients. ©2005 Baylor Health Care System. All rights reserved.